Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.
Annalisa RuggeriMyriam LabopinAndrea BacigalupoBoris AfanasyevJan J CornelissenAhmet ElmaagacliMaija Itälä-RemesDidier BlaiseEllen MeijerYener KocNoel MilpiedHarry C SchoutenNicolaus KroegerMohamad MohtyArnon NaglerPublished in: Journal of hematology & oncology (2018)
For GVHD prophylaxis in MSD and UD HSCT, the addition of IS drugs to PT-Cy enhances its effect and reduces the risk of severe cGVHD, reducing mortality and improving survival.